We design customized panels using multi-parametric markers to identify rare, tissue-specific subpopulations across diverse oncology research models.
Learn More →Cancer Stem Cell Diagnostic & Predictive Testing Services
Creative Biolabs provides a robust suite of analytical services focused on the identification and functional characterization of cancer stem cells (CSCs). Our services encompass high-dimensional phenotypic profiling, 3D functional modeling, and predictive sensitivity screening. Clients can expect to gain high-fidelity data regarding the metastatic potential of their cell populations, validation of drug mechanisms against resistant sub-clones, and comprehensive bioinformatic reports that streamline the transition from lead optimization to preclinical development.
Introduction What We Can Offer How We Can Help Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us
Foundations of Cancer Stem Cell Diagnostic & Predictive Testing
Cancer stem cells represent the biological cornerstone of resistance in oncology research. Peer-reviewed literature confirms that while traditional approaches target the bulk cellular mass, CSCs utilize metabolic switching and epigenetic memory to survive. These "seeds" reside in protective spatial niches within the microenvironment. Our services provide a rigorous scientific framework to identify these cells, leveraging two decades of Creative Biolabs expertise to ensure that your oncology research addresses the drivers of malignancy.
Request a Consultation →
Fig.1 Overview of the methods used to detect CSCs from patient samples. 1
What We Can Offer
Customized Biomarker Panel Development
We design bespoke multi-parametric flow cytometry panels targeting tissue-specific markers, ensuring high-resolution identification of rare cell subpopulations for your unique research requirements.
Scalable Functional Assays
Our high-throughput 3D spheroid and organoid systems allow researchers to evaluate hundreds of therapeutic combinations simultaneously under biologically relevant growth conditions.
Metabolic and Epigenetic Profiling
We integrate specialized OXPHOS analysis and epigenetic tracking to reveal how metabolic shifts and stable memory mechanisms drive long-term resistance in models.
Precision Enrichment Technologies
Utilizing proprietary microfluidic and magnetic sorting protocols, we isolate viable, ultra-rare target populations with high purity even from the most complex backgrounds.
How Creative Biolabs Can Assist Your Project
CSCs Biomarker Detection Panel Development
CSCs Cell Detection
We isolate and characterize rare metastasis-initiating cells from liquid research samples to study biological drivers of systemic spread.
Learn More →CSCs Exosome Biomarker Detection
Our team analyzes signaling vesicles released by target cells to investigate how they prepare remote niches for regrowth.
Learn More →CSCs Immune Checkpoint Expression Testing
We map inhibitory ligands on research-grade stem cells to evaluate their ability to evade detection in complex environments.
Learn More →CSCs Burden Dynamic Monitoring
Researchers can track quantitative fluctuations in target cell populations over time to evaluate the longitudinal impact of candidates.
Learn More →CSCs Recurrence & Metastasis Risk Prediction
We provide high-resolution analytical scoring based on functional self-renewal capacity to estimate the metastatic potential of samples.
Learn More →Highlights
Functional Accuracy Priority
Our commitment to operational excellence ensures all research data reflects true biological potential rather than relying on static genomic snapshots which often overlook dynamic resistance.
Live-Cell Analysis
We provide sophisticated live-cell functional readouts that capture real-time cellular behaviors and adaptive responses to diverse therapeutic stressors within a relevant microenvironmental context.
High-Resolution Signatures
Our platforms detect highly specific molecular signatures in circulating populations, providing researchers with unparalleled clarity into the underlying mechanisms that drive systemic metastatic spread.
Deep Biological Insight
By integrating phenotypic and functional data, we offer researchers profound insights into the most elusive drivers of therapy resistance and long-term tumor survival.
Get a quote today to see how Creative Biolabs can accelerate your path to identifying breakthrough therapeutics.
Customer Reviews
-
Exceptional Functional Data
Using Creative Biolabs' Spheroid Assays in our research has significantly improved our understanding of tumor heterogeneity. Their viability maintenance is far superior to other vendors. - Prof. E**a. V. -
Optimized Pipeline
Creative Biolabs' Predictive Testing has significantly facilitated our lead optimization phase. We realized our primary candidate was effective against bulk cells but left the CSCs untouched. - M**l R.
FAQs
How does your CSC testing differ from standard CTC analysis?
Standard analysis counts all circulating tumor cells regardless of function, whereas Creative Biolabs specifically isolates the rare subpopulation with high metastatic potential and self-renewal capacity.
Can we use research-derived tissue for these tests?
Yes, our protocols accommodate both liquid biopsies and solid tissue fragments, using specialized functional assays to ensure live-cell stemness characteristics are preserved for accurate research results.
Related Services
In Vivo Modeling Services of Anti-Cancer Resistance
We provide specialized animal models to evaluate drug resistance mechanisms and validate the longitudinal therapeutic impact of candidates in vivo.
Learn More →Cancer Stem Cell Functional In Vitro & In Vivo Analysis
We integrate advanced 3D cell culture and xenograft assays to evaluate self-renewal and metastasis-initiating potential across multiple biological levels.
Learn More →How to Contact Us
Creative Biolabs provides the most comprehensive and functionally-validated CSCs research & predictive testing services available for the pharmaceutical and laboratory sectors. From identifying metastatic-initiating signatures to screening drug libraries against therapy-resistant organoids, we ensure your oncology research is built on solid scientific ground.
We invite you to contact our specialists for detailed project discussions or to receive a customized quote.
Reference
- Hakala, Sofia et al. "Detection of Cancer Stem Cells from Patient Samples." Cells vol. 14,2 148. 20 Jan. 2025, doi:10.3390/cells14020148. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cells14020148
Download our brochureLoading case studies...
Online Inquiry